11/21
06:14 am
ctlt
FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND) [Yahoo! Finance]
Low
Report
FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND) [Yahoo! Finance]
11/20
07:07 am
ctlt
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery [Yahoo! Finance]
Low
Report
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery [Yahoo! Finance]
11/18
08:00 am
ctlt
Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer [Yahoo! Finance]
Low
Report
Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer [Yahoo! Finance]
11/18
07:12 am
ctlt
Pharmaceutical Outsourcing Launches New Clinical Trials Documentary: Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs [Yahoo! Finance]
Low
Report
Pharmaceutical Outsourcing Launches New Clinical Trials Documentary: Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs [Yahoo! Finance]
11/15
09:09 am
ctlt
OpenText World 2024 Unites Industry Leaders to Tackle AI and Information Management [Yahoo! Finance]
Low
Report
OpenText World 2024 Unites Industry Leaders to Tackle AI and Information Management [Yahoo! Finance]
11/14
05:13 am
ctlt
High Potency API Contract Manufacturing Market Forecast, 2025-2030 - Rising Demand for Oncology Drugs and Advancements in Manufacturing Technology Driving the Industry at 10.98% CAGR [Yahoo! Finance]
Low
Report
High Potency API Contract Manufacturing Market Forecast, 2025-2030 - Rising Demand for Oncology Drugs and Advancements in Manufacturing Technology Driving the Industry at 10.98% CAGR [Yahoo! Finance]
11/14
03:11 am
ctlt
Catalent, Inc. (NYSE: CTLT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Catalent, Inc. (NYSE: CTLT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/13
12:45 pm
ctlt
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal [Yahoo! Finance]
Low
Report
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal [Yahoo! Finance]
11/6
11:09 pm
ctlt
Catalent, Inc. (NYSE: CTLT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Catalent, Inc. (NYSE: CTLT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/6
11:56 am
ctlt
Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook [Yahoo! Finance]
Low
Report
Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook [Yahoo! Finance]
11/6
10:15 am
ctlt
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up [Yahoo! Finance]
Low
Report
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up [Yahoo! Finance]
11/5
10:05 am
ctlt
Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/5
07:36 am
ctlt
Catalent reports Q1 loss, misses market expectations [Yahoo! Finance]
Low
Report
Catalent reports Q1 loss, misses market expectations [Yahoo! Finance]
11/5
07:00 am
ctlt
Catalent, Inc. Reports First Quarter Fiscal 2025 Results
Low
Report
Catalent, Inc. Reports First Quarter Fiscal 2025 Results
11/4
03:04 am
ctlt
EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6 [Yahoo! Finance]
Low
Report
EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6 [Yahoo! Finance]
10/29
07:30 am
ctlt
Ardena Expands Bioanalytical Services in Europe [Yahoo! Finance]
Low
Report
Ardena Expands Bioanalytical Services in Europe [Yahoo! Finance]
10/29
07:30 am
ctlt
Ardena Expands Bioanalytical Services in Europe [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Ardena Expands Bioanalytical Services in Europe [Financial Post (Toronto, Ontario, Canada)]
10/24
12:24 pm
ctlt
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases [Yahoo! Finance]
Low
Report
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases [Yahoo! Finance]
10/23
07:21 pm
ctlt
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition [Yahoo! Finance]
Low
Report
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition [Yahoo! Finance]
10/23
04:46 am
ctlt
Roche comes out against clearing takeover of drug manufacturer Catalent [Yahoo! Finance]
Low
Report
Roche comes out against clearing takeover of drug manufacturer Catalent [Yahoo! Finance]
10/23
04:46 am
ctlt
Roche comes out against clearing takeover of drug manufacturer Catalent [Yahoo! Finance Canada]
Low
Report
Roche comes out against clearing takeover of drug manufacturer Catalent [Yahoo! Finance Canada]
10/21
09:39 am
ctlt
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout [Yahoo! Finance]
Low
Report
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout [Yahoo! Finance]
10/21
07:38 am
ctlt
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout [Yahoo! Finance Canada]
Low
Report
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout [Yahoo! Finance Canada]
10/21
07:29 am
ctlt
Catalent's Maselli to continue as CEO post Novo Holdings deal close [Seeking Alpha]
Low
Report
Catalent's Maselli to continue as CEO post Novo Holdings deal close [Seeking Alpha]
10/21
07:00 am
ctlt
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
Low
Report
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings